Cargando…
A Nanobody-Mediated Virus-Targeting Drug Delivery Platform for the Central Nervous System Viral Disease Therapy
Viral diseases of the central nervous system (CNS) represent a major global health concern. Difficulties in treating these diseases are caused mainly by the biological tissues and barriers, which hinder the transport of drugs into the CNS. To counter this, a nanobody-mediated virus-targeting drug de...
Autores principales: | Zhu, Song, Luo, Fei, Zhu, Bin, Ling, Fei, Wang, Er-Long, Liu, Tian-Qiang, Wang, Gao-Xue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8612154/ https://www.ncbi.nlm.nih.gov/pubmed/34817277 http://dx.doi.org/10.1128/Spectrum.01487-21 |
Ejemplares similares
-
Nanomaterials for Drug Delivery to the Central Nervous System
por: Teleanu, Daniel Mihai, et al.
Publicado: (2019) -
A resource of high-quality and versatile nanobodies for drug delivery
por: Shen, Zhuolun, et al.
Publicado: (2021) -
Non-Viral Nucleic Acid Delivery Strategies to the Central Nervous System
por: Tan, James-Kevin Y., et al.
Publicado: (2016) -
Non-Viral Delivery of RNA Gene Therapy to the Central Nervous System
por: Hauck, Ellen S., et al.
Publicado: (2022) -
Strategies for Enhanced Drug Delivery to the Central Nervous System
por: Dwibhashyam, V. S. N. M., et al.
Publicado: (2008)